Company news
Replimune Group, Inc. news in 2020
Replimune Group, Inc.'s news releases, calls and decks from 2020, newest first.
Replimune to Participate at the SVB Leerink Oncology 1x1 Day
November 11, 2020
Replimune Announces Poster Presentations at the SITC 2020 Annual Meeting and a Presentation at the SITC 2020 Annual Meeting Virtual Press Conference
November 8, 2020
Replimune Releases Updated Corporate Presentation
October 19, 2020
Replimune Appoints Tanya Lewis to the Board of Directors
October 18, 2020
Replimune Announces Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 13, 2020
Replimune to Participate at the Chardan Virtual 4th Annual Genetic Medicines Conference
September 30, 2020
Replimune Appoints Andrea Pirzkall, M.D. as Chief Medical Officer
July 21, 2020
Biodesix Appoints Jean Franchi and Hany Massarany to Board of Directors
July 19, 2020
Replimune to Participate at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference
June 16, 2020
Replimune Reports Fiscal Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
June 2, 2020
Replimune Provides RP1 Data Update from its Phase 2 Cohorts in Melanoma and Non-Melanoma Skin Cancer that Strongly Support Replimune’s Ongoing Registration-Directed Clinical Trials with RP1
June 2, 2020
Replimune to Provide Data Update on June 3, 2020
April 29, 2020
Replimune Appoints Dieter Weinand as Chairman and Paolo Pucci to the Board of Directors
April 1, 2020
Replimune Provides 2019 Year End Corporate Update and Reviews Expected 2020 Milestones
January 12, 2020
Replimune Announces the Evolution of its Management Team as it Advances Through Later Stage Clinical Development and Prepares for Commercialization
January 8, 2020
Replimune to Present at the 38th Annual J.P.Morgan Healthcare Conference
January 6, 2020
Decks in 2020
- Investor Presentation (October 2020)
Investor deck · 25 slides · Oct 20, 2020
- Corporate Update (June 2020)
Corporate update · 64 slides · Jun 3, 2020